1 / 5

Erik Roelofs MSc Medical Physicist MAASTRO clinic Maastricht, Juli 2011

Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer. Erik Roelofs MSc Medical Physicist MAASTRO clinic Maastricht, Juli 2011. Flowchart to determine eligibility of a patient to receive proton therapy.

alyson
Télécharger la présentation

Erik Roelofs MSc Medical Physicist MAASTRO clinic Maastricht, Juli 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer Erik Roelofs MSc Medical Physicist MAASTRO clinic Maastricht, Juli 2011

  2. Flowchart to determine eligibility of a patient to receive proton therapy. *Using peer-reviewed, published and externally validated models. Roelofs et al., J. Thorac Oncol, 2011

  3. 3DCRT IMRT PSPT #2 #6 Comparison of dose distributions of 3DCRT, IMRT and PSPT treatment plans (columns) for three cases (rows). The target is shown (thick red line) with isodose lines of 1, 10, 25, 50 and 67 Gy (thin red line). Roelofs et al., J. Thorac Oncol, 2011 #15

  4. DVHs for patient #2 – Prescribed dose (70Gy) DVHs for patient #2 where the prescribed dose of 70 Gy resulted in exceeding the critical MLD level. Shown are DVHs for 3DCRT (solid), IMRT (dashed) and PSPT (dotted) plans.*MLD refers to the DVH of both left and right lung volumes minus the GTV. Roelofs et al., J. Thorac Oncol, 2011

  5. DVHs for patient #2 – Maximum Tolerable Dose DVHs for patient #2 where the dose was lowered to the maximum tolerable dose, showing larger under-dosage for 3DCRT (solid) than for IMRT (dashed) or PSPT (dotted).*MLD refers to the DVH of both left and right lung volumes minus the GTV. Roelofs et al., J. Thorac Oncol, 2011

More Related